Shop

Zytiga 250 mg Tablet (Abiraterone Acetate) is a targeted oral therapy used with prednisone to treat metastatic castration-resistant prostate cancer (mCRPC). Abiraterone blocks CYP17 enzymes, which are essential to testosterone production, thereby reducing hormone-driven cancer progression.

Each bottle contains 250 mg Abiraterone Acetate tablets, taken once daily on an empty stomach to ensure proper absorption. Patients also take prednisone as prescribed to reduce side effects like fluid retention and hypertension and to support hormone balance.

Clinicians typically recommend Zytiga for men whose cancer has progressed despite surgical or chemical castration. The medication helps slow tumor growth, decrease PSA levels, improve symptoms, and prolong survival.

Common side effects include fatigue, joint swelling, hypertension, low potassium, and fluid buildup. Serious risks like liver toxicity, adrenal insufficiency, and cardiac events require regular monitoring of liver enzymes, blood pressure, and electrolytes.

Store Zytiga tablets at room temperature (below 25 °C) in a dry place, protected from light. Keep them out of children’s reach.